1. Szabo G，Dolganiuc A. Hepatitis C and innate immunity：recent advances. Clin Liver Dis 2008；12（3）：675-692.

2. Barton G M. Viral recognition by Toll-like receptors. Semin Immunol 2007；19（1）：33-40.

3. Bowie A G，Fitzgerald KA. RIG-I：tring to discriminate between self and non-self RNA. Trends Immunol 2007；28（4）：147-150.

4. Quiroga J A，van Binsbergen J，Wang C Y，et al. Immunoglobulin M antibody to hepatitis C virus core antigen：correlations with viral replication，histological activity，and liver disease outcome. Hepatology 1995；22（6）：1635-1640.

5. Kundig T M，Bachmann M F，Oehen S，et al. On the role of antigen in maintaining cytotoxic T-cell memory. Proc Natl Acad Sci 1996；93（18）：9716-9723.

6. Farci P，Shimoda A，Wong D，et al. Prevention of hepatitis C virus infection in chimpanzees by hyperimmune serum against the hypervariable region 1 of the envelope 2 protein. Proc Natl Acad Sci USA 1996；93（26）：15394-15399.

7. Shimizu YK，Igarashi H，Kiyohara T，et al. A hyperimmune serum against a synthetic peptide corresponding to the hypervariable region 1 of hepatitis C virus can prevent viral infection in cell cultures. Virology 1996；223（2）：409-412.